News

Stay Updated! In The World Of Investments!
Sensex 48295.00 411.62 (0.86%)

Hester Biosciences Latest News

08

Apr, 2021

Hester shines on acquiring technology for production, commercialization of classical swine fever vaccine, sheep pox vaccine

Hester Biosciences is currently trading at Rs. 2160.00, up by 146.95 points or 7.30% from its previous closing of Rs. 2013.05 on the BSE.

The scrip opened at Rs. 2027.05 and has touched a high an...

Read More

08

Apr, 2021

Hester acquires technology for production, commercialization of classical swine fever vaccine, sheep pox vaccine

Hester Biosciences has signed two agreements with ICAR-IVRI (Indian Council of Agricultural Research - Indian Veterinary Research Institute), for acquiring technologies for the production and commercialisation of the vaccines -...

Read More

08

Mar, 2021

Hester Biosciences submits proceedings of postal ballot process

Hester Biosciences has informed that it enclosed the proceedings of Postal Ballot Process to get approval of members on special resolutions mentioned in Postal Ballot Notice dated 30.01.2021 and results of voting of...

Read More

27

Jan, 2021

Hester Biosciences informs about conference call

Hester Biosciences has informed that as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has arranged earnings conference call on Saturday, 30.01.2021 at 2...

Read More

29

Dec, 2020

Hester Biosciences informs about closure of trading window

Pursuant SEBI (Prohibition of Insider Trading) Regulations and the code of conduct of the Company to Regulate, Monitor and Report Trading by Directors, Promoters, Designated Employees and Specified Connected Persons...

Read More

23

Nov, 2020

Hester Biosciences' Nepal JV launches Live Thermo-tolerant PPR Vaccine

Hester Biosciences' joint venture (JV) company -- Hester Biosciences Nepal has successfully developed and launched its Live Thermo-tolerant PPR (Peste Des Petits) Vaccine - Nigerian 75/1 Strain, under ...

Read More

04

Nov, 2020

Hester Biosciences submits transcript of earnings con call

Hester Biosciences has submitted a transcript of Earnings Conference Call held by the Management of the Company with investors on Saturday, 31.10.2020 at 2:00 pm to discuss the Standalone and Consolidated Unaudited ...

Read More

31

Oct, 2020

Hester Biosciences board approves unaudited financial results

Hester Biosciences has informed that pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors in their Meeting held today, have approved the Standalone and Con...

Read More

23

Sep, 2020

Hester jumps on acquiring technology from ICAR - IVRI to develop Brucella Abortus S19 Delta Per Vaccine

Hester Biosciences is currently trading at Rs. 1725.00, up by 14.50 points or 0.85% from its previous closing of Rs. 1710.50 on the BSE.

The scrip opened at Rs. 1742.00 and has touched a high and...

Read More

23

Sep, 2020

Hester acquires technology from ICAR - IVRI to develop Brucella Abortus S19 Delta Per Vaccine

Hester Biosciences has signed the agreement towards receiving the indigenously developed technology from ICAR-IVRI (Indian Council of Agriculture Research - Indian Veterinary Research Institute), for developing the ...

Read More

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback